BORELLA, MIRIAM
 Distribuzione geografica
Continente #
EU - Europa 15
NA - Nord America 12
AS - Asia 1
Totale 28
Nazione #
US - Stati Uniti d'America 11
FR - Francia 4
IE - Irlanda 3
IT - Italia 3
RU - Federazione Russa 2
UA - Ucraina 2
CA - Canada 1
DE - Germania 1
IN - India 1
Totale 28
Città #
Columbus 3
Dublin 3
Florence 3
Moscow 2
Ann Arbor 1
Ashburn 1
Boardman 1
Fleming Island 1
Lincoln 1
Los Angeles 1
Pune 1
Seattle 1
Toronto 1
Woodbridge 1
Totale 21
Nome #
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study, file e398c382-3e4c-179a-e053-3705fe0a4cff 22
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis, file 3bd5c24b-01ee-4d48-89e4-f7038f518897 4
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib, file 391ace5a-5bf4-41f1-bb6a-1f8444ad6c74 2
Totale 28
Categoria #
all - tutte 167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 0 0 0 1 2
2022/202311 2 0 0 1 0 1 3 0 1 0 2 1
2023/202414 0 0 1 0 0 1 1 3 3 2 3 0
Totale 28